tiprankstipranks
Trending News
More News >
Apotea AB (SE:APOTEA)
:APOTEA
Sweden Market
Advertisement

Apotea AB (APOTEA) Technical Analysis

Compare
1 Followers

Summary of all the Indicators

Overall Consensus
Sell
5Bullish
2Neutral
15Bearish
Technical Analysis Consensus
Buy
5Bullish
2Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Apotea AB’s (APOTEA) Moving Averages Convergence Divergence (MACD) indicator is -3.08, suggesting Apotea AB is a Buy.
Apotea AB’s (APOTEA) 20-Day exponential moving average is 87.02, while Apotea AB’s (APOTEA) share price is kr81.47, making it a Sell.
Apotea AB’s (APOTEA) 50-Day exponential moving average is 91.52, while Apotea AB’s (APOTEA) share price is kr81.47, making it a Sell.

Apotea AB (APOTEA) Pivot Points

Nov 07, 2025, 02:40 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
78.72
79.37
79.90
80.55
81.08
81.73
82.26
Fibonacci
79.37
79.82
80.10
80.55
81.00
81.28
81.73
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Apotea AB (APOTEA) Moving Averages

Nov 07, 2025, 02:40 AM
Period
Simple
Exponential
MA5
81.82Sell
82.28Sell
MA10
85.23Sell
84.42Sell
MA20
88.36Sell
87.02Sell
MA50
91.85Sell
91.52Sell
MA100
97.32Sell
93.29Sell
MA200
89.46Sell
88.39Sell
Apotea AB’s (APOTEA) 10-Day exponential moving average is 84.42, while Apotea AB’s (APOTEA) share price is kr81.47, making it a Sell.
Apotea AB’s (APOTEA) 100-Day exponential moving average is 93.29, while Apotea AB’s (APOTEA) share price is kr81.47, making it a Sell.
Apotea AB’s (APOTEA) stock price is kr81.47 and Apotea AB’s (APOTEA) 50-day simple moving average is 91.85, creating a Sell signal.
Apotea AB’s (APOTEA) stock price is kr81.47 and Apotea AB’s (APOTEA) 100-day simple moving average is 97.32, creating a Sell signal.
Apotea AB’s (APOTEA) stock price is kr81.47 and Apotea AB’s (APOTEA) 200-day simple moving average is 89.46, creating a Sell signal.

Apotea AB (APOTEA) Technical Indicators

Nov 07, 2025, 02:40 AM
Name
Value
Implied Action
RSI (14)
30.47
Neutral
STOCH (9,6)
5.69
Buy
STOCHRSI (14)
5.22
Buy
MACD (12,26)
-3.08
Buy
ADX (14)
29.71
Neutral
Williams %R
-90.00
Buy
CCI (14)
-137.00
Buy
ATR (14)
2.61
-
Ultimate Oscillator
26.26
Sell
ROC
-13.85
Sell
Apotea AB’s (APOTEA) Relative Strength Index (RSI) is 30.47, creating a Neutral signal.
Apotea AB’s (APOTEA) Trend Strength Indicator (ADX) is 29.71, creating a Neutral signal.
Apotea AB’s (APOTEA) Commodity Channel Index (CCI) is -137.00, creating a Buy signal.
Apotea AB’s (APOTEA) Price Rate of Change (ROC) is -13.85, creating a Sell signal.

FAQ

Is APOTEA a Buy, Hold, or Sell?
Based on APOTEA’s technical indicators, APOTEA is a Sell.
    What is APOTEA’s RSI (14)?
    APOTEA’s RSI (14) is 30.47, which suggests APOTEA is a Neutral.
      What is APOTEA’s MACD?
      APOTEA’s MACD is -3.08, which suggests APOTEA is a Buy.
        What is APOTEA’s 5-day moving average?
        APOTEA’s 5-day moving average is 81.82, which suggests APOTEA is a Sell.
          What is APOTEA’s 20-day moving average?
          APOTEA 20-day moving average is 88.36, which suggests APOTEA is a Sell.
            What is APOTEA’s 50-day moving average?
            APOTEA’s 50-day moving average is 91.85, which suggests APOTEA is a Sell.
              What is APOTEA’s 200-day moving average?
              APOTEA’s 200-day moving average is 89.46, which suggests APOTEA is a Sell.
                What is APOTEA’s Williams % R (14)?
                APOTEA’s Williams % R (14) is -90.00, which suggests APOTEA is a Buy.
                  What is APOTEA’s CCI (14)?
                  APOTEA’s CCI (14) is -137.00, which suggests APOTEA is a Buy.
                    What is the share price of Apotea AB?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis